Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-17

FDA Approved: TZIELD — Original Application (Provention Bio, Inc.)

View source ↗

Summary

The FDA approved TZIELD (teplizumab-mzwv) in an original Biologics License Application to delay the onset of stage 3 type 1 diabetes in individuals at elevated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TZIELD (TEPLIZUMAB-MZWV)

Snippet

ORIG AP for TZIELD (TEPLIZUMAB-MZWV)